Finally, we got the opportunity to speak with Antony about today company update and ask a few questions we hope shareholders find informative. What is cleary stated, P2F’s company portfolio is broader than the current focuses on mask production.
Antony Legge, Executive Chairman of RMS, said; “We are very pleased to update the market with the positive developments achieved by the P2F team. Whilst a number of issues remain with the machine at BioCity, the purchase order with Volz coupled with the intentions by both parties to enter into a more formal outsourced manufacturing agreement means P2F can commence sales with confidence as we anticipate a continuing market need for P2F’s proprietary α-virion material, notwithstanding the progress of various national Covid-19 vaccination programmes.”
·Order for 1.0 million of P2F’s masks placed with Volz with outsourcing manufacturing discussions in progress
· Distribution agreement to make masks available in UK & Europe via Amazon
· Launch of web site for the P2F mask
· Independent adviser and line manager appointed to bring mask machine into full operation
P2F is in discussions with Lemu Group, the manufacturer of the mask making machine, regarding mechanical issues that need to be resolved before the machine at BioCity can be considered to be fully commissioned. The Company has agreed to appoint Egremont Capital Limited (“Egremont”) as an independent advisor for the next three months to assist with development of P2F’s production capabilities. Jonathan Hall, Egremont’s founder, has a background in production manufacturing, in addition to Egremont’s expertise as a corporate advisor. In addition to a monthly fee, Egremont may be issued with up to 500,000 new ordinary shares dependent on achieving certain production milestones. In addition, a line manager has been recruited at BioCity to strengthen the production team.
If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates.
Terms of Website Use
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned